Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8003651B2 · kind B2 · utility
29Cited by
24References
76Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 5, 2007 |
| Grant date | Aug 23, 2011 |
| Priority date | — |
| Expiry date | Apr 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.